InnoCare Pharma Ltd. (HK:9969) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
InnoCare Pharma Ltd. has announced the grant of 3,830,000 restricted share units (RSUs) under their 2023 Share Award Scheme, representing 0.22% of the company’s total shares. These RSUs, granted to six employees, come with performance-based vesting conditions tied to both corporate achievements and individual performance evaluations. The scheme includes a clawback mechanism to reclaim unvested or vested awards under certain conditions.
For further insights into HK:9969 stock, check out TipRanks’ Stock Analysis page.